Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium

Launched by SCIENSANO · Jun 22, 2020

Keywords

ClinConnect Summary

This clinical trial, taking place in Belgium, is studying infections caused by a type of bacteria called Streptococcus pneumoniae, which can lead to conditions like pneumonia, sinusitis, and ear infections (otitis media). The goal is to better understand how common these infections are and to analyze the different types of this bacteria. This information will help evaluate how effective national vaccination programs are in protecting people from these infections.

To participate in the study, patients must be living in Belgium and have had samples taken from non-invasive sites, like nasal fluid or sputum, showing the presence of S. pneumoniae. This includes individuals diagnosed with pneumonia, sinusitis, or ear infections. However, patients who have the bacteria in their blood or other normally sterile areas will not be eligible. Participants can expect to contribute to important research that may help improve health strategies against these infections. The study is currently recruiting participants of all ages and genders.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients living in Belgium at the time of the study,
• • from whom unduplicated S. pneumoniae isolates were collected in routine practices,
• • from non-invasive upper (e.g.: pus/fluid from nasal sinus or from otitis media fluid) or lower respiratory tract (e.g. sputum bronchial or endotracheal aspirate, bronchoalveolar fluid (BAL),...) clinical samples,
• • from patients diagnosed with pneumonia, sinusitis and otitis.
• Exclusion Criteria:
• • • Patients for whom S. pneumoniae was simultaneously isolated from blood or another usually sterile specimen